GHW CPHI Frankfurt 2025 Concludes Successfully!

CPHI Frankfurt, the annual grand event in the global pharmaceutical industry, came to a successful conclusion at the Messe Frankfurt Exhibition Center in Germany from October 28th to 30th, 2025!

This year's exhibition gathered more than 2,400 exhibitors from 166 countries including China, India, Germany, Italy, Spain, the United States, Canada, South Korea, Portugal, Switzerland and Turkey, attracting over 62,000 professional visitors to participate actively. The exhibition scope covers multiple fields such as pharmaceutical ingredients, fine chemicals, pharmaceutical excipients, formulations, comprehensive pharmaceuticals, natural extracts, biopharmaceuticals, pharmaceutical equipment, packaging and drug delivery systems, contract manufacturing and services, as well as contract research and development services.

For this trip to Frankfurt, Mr. Yin Yanbin, Chairman of GHW International, and Mr. Zhuang Zhaohui, Executive Director, led the team in person. Members of the iodine derivatives series and supporting products, methylamine industry series, and greater health products business teams from Nanjing headquarters made a stunning appearance with some of the company's core products.

At the exhibition site, focusing on the company's products such as potassium iodide, potassium iodate, calcium iodate, sodium periodate, sodium selenite, iodomethane, IPBC, choline chloride and betaine, the business personnel provided visiting customers with comprehensive product introductions, technical answers and solution services with professional knowledge and full enthusiasm. This fully demonstrated the company's core strength, technical achievements and service advantages in the field of bulk drug.

During the exhibition, the company's booth attracted representatives of pharmaceutical enterprises, industry experts and potential partners from many countries around the world to stop and communicate. Business personnel analyzed industry trends face-to-face with customers and recorded personalized needs. After a comprehensive understanding of the products and the company's strength, many customers showed strong willingness to cooperate and held in-depth discussions with the company's business personnel on future business cooperation.

By participating in CPHI Frankfurt 2025, GHW not only demonstrated its strong strength in the fields of iodine derivatives, methylamine and greater health, but also further consolidated its brand recognition in the European and even global markets.

The exhibition has concluded successfully, but cooperation has just begun — we would like to thank all customers and partners who visited the exhibition for communication and guidance. GHW looks forward to meeting you next time!